Strategies to Navigate + Overcome Step Edit Barriers
Login to Watch this Webinar
To watch the live webinar, login to your account or register to gain access to our exclusive content.
Even when the clinical rationale is clear, navigating step edit requirements can still create delays, additional documentation demands, and difficult access conversations across oncology care teams.
In this session, Melissa Shimanek, PharmD, BCACP (Rocky Mountain Cancer Centers), will focus on practical strategies for responding to payer restrictions and reducing barriers to Bruton’s tyrosine kinase inhibitor (BTKi) therapy initiation. Drawing from real-world oncology practice considerations, Melissa will explore how teams can strengthen appeals processes, support care coordination, and advocate for evidence-based treatment selection while managing evolving payer requirements.
What you’ll learn
- Documentation approaches that may strengthen step edit exceptions and appeal submissions
- Developing a more consistent, patient-specific appeals process
- Multidisciplinary workflow strategies aimed at reducing delays in BTKi initiation
- Navigating payer restrictions while supporting evidence-based treatment decisions
For additional information or login assistance, reach out to NCODA’s Jonathan Rivera.
